S. V. Burov

860 total citations
54 papers, 702 citations indexed

About

S. V. Burov is a scholar working on Molecular Biology, Organic Chemistry and Biomaterials. According to data from OpenAlex, S. V. Burov has authored 54 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Organic Chemistry and 10 papers in Biomaterials. Recurrent topics in S. V. Burov's work include Chemical Synthesis and Analysis (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Glycosylation and Glycoproteins Research (4 papers). S. V. Burov is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Glycosylation and Glycoproteins Research (4 papers). S. V. Burov collaborates with scholars based in Russia, Canada and France. S. V. Burov's co-authors include Елена Марквичева, Dizhe Eb, Perevozchikov Ap, Sergey Orlov, Roman Akasov, Luisa Perasso, Maurizio Balestrino, Daria Zaytseva‐Zotova, Myron R. Szewczuk and Pavel S. Chelushkin and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Chemical Physics and Chemical Communications.

In The Last Decade

S. V. Burov

46 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. V. Burov Russia 16 373 119 111 101 93 54 702
Elena Karnaukhova United States 19 430 1.2× 70 0.6× 133 1.2× 31 0.3× 64 0.7× 48 899
Craig T. Armstrong United Kingdom 14 569 1.5× 122 1.0× 69 0.6× 38 0.4× 62 0.7× 15 824
Meifang Yu China 9 715 1.9× 137 1.2× 95 0.9× 56 0.6× 278 3.0× 23 1.2k
Biswarup Saha United States 17 671 1.8× 56 0.5× 131 1.2× 41 0.4× 90 1.0× 27 1.0k
Silvia Ronchi Italy 20 536 1.4× 61 0.5× 49 0.4× 32 0.3× 108 1.2× 62 938
N. Sukumar United States 15 504 1.4× 96 0.8× 40 0.4× 35 0.3× 84 0.9× 35 827
Amy B. Foraker United States 12 450 1.2× 67 0.6× 90 0.8× 22 0.2× 137 1.5× 13 792
Amy Schutz‐Geschwender United States 13 587 1.6× 33 0.3× 120 1.1× 62 0.6× 188 2.0× 15 943
Wendi V. Rodrigueza United States 16 819 2.2× 99 0.8× 151 1.4× 32 0.3× 55 0.6× 22 1.4k

Countries citing papers authored by S. V. Burov

Since Specialization
Citations

This map shows the geographic impact of S. V. Burov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. V. Burov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. V. Burov more than expected).

Fields of papers citing papers by S. V. Burov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. V. Burov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. V. Burov. The network helps show where S. V. Burov may publish in the future.

Co-authorship network of co-authors of S. V. Burov

This figure shows the co-authorship network connecting the top 25 collaborators of S. V. Burov. A scholar is included among the top collaborators of S. V. Burov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. V. Burov. S. V. Burov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Burov, S. V., et al.. (2025). Solid‐Phase Synthesis of Peptide Hydrazides: Moving Toward Green Chemistry. Journal of Peptide Science. 31(4). e70010–e70010. 3 indexed citations
3.
4.
Sambi, Manpreet, Bessi Qorri, Sabah Haq, et al.. (2020). <p>A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer</p>. Drug Design Development and Therapy. Volume 14. 1995–2019. 20 indexed citations
5.
Gretskaya, N. M., Roman Akasov, S. V. Burov, et al.. (2020). Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models. European Journal of Pharmacology. 883. 173346–173346. 10 indexed citations
6.
Burov, S. V., et al.. (2019). Lipoamino acid-based cerasomes for doxorubicin delivery: Preparation and in vitro evaluation. Materials Science and Engineering C. 100. 724–734. 13 indexed citations
7.
Марквичева, Елена, et al.. (2019). <p>Impact of Fucosylation on Self-Assembly of Prostate and Breast Tumor Spheroids by Using Cyclo-RGDfK(TPP) Peptide and Image Object Detection</p>. OncoTargets and Therapy. Volume 12. 11153–11173. 3 indexed citations
8.
Ryabaya, O. O., Roman Akasov, Д. А. Хоченков, et al.. (2018). Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells. Biomedicine & Pharmacotherapy. 109. 2548–2560. 27 indexed citations
9.
Haq, Sabah, Fiona Haxho, Roman Akasov, et al.. (2017). Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide. OncoTargets and Therapy. Volume 10. 2427–2447. 12 indexed citations
10.
Akasov, Roman, Daria Zaytseva‐Zotova, S. V. Burov, et al.. (2016). Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro. International Journal of Pharmaceutics. 506(1-2). 148–157. 46 indexed citations
11.
Akasov, Roman, Daria Zaytseva‐Zotova, S. V. Burov, et al.. (2016). 3D in vitro co-culture models based on normal cells and tumor spheroids formed by cyclic RGD-peptide induced cell self-assembly. Biotechnology Letters. 39(1). 45–53. 15 indexed citations
12.
Burov, S. V., et al.. (2016). Contrast agents for magnetic resonance imaging based on dendronized N-vinylpyrrolidone polymers. Doklady Chemistry. 466(1). 18–20.
13.
Burov, S. V., et al.. (2011). Creatinyl amino acids—new hybrid compounds with neuroprotective activity. Journal of Peptide Science. 17(9). 620–626. 21 indexed citations
14.
Perasso, Luisa, Enrico Adriano, Piero Ruggeri, et al.. (2009). In vivo neuroprotection by a creatine-derived compound: Phosphocreatine–Mg-complex acetate. Brain Research. 1285. 158–163. 24 indexed citations
15.
Perasso, Luisa, Carlo Gandolfo, Tullio Florio, et al.. (2007). Protective Effects of Some Creatine Derivatives in Brain Tissue Anoxia. Neurochemical Research. 33(5). 765–775. 24 indexed citations
16.
Parodi, Alessandro, Luisa Perasso, Enrico Adriano, et al.. (2006). The creatine transporter mediates the uptake of creatine by brain tissue, but not the uptake of two creatine-derived compounds. Neuroscience. 142(4). 991–997. 44 indexed citations
17.
Eb, Dizhe, et al.. (2006). Complexes of DNA with cationic peptides: Conditions of formation and factors effecting internalization by mammalian cells. Biochemistry (Moscow). 71(12). 1350–1356. 14 indexed citations
18.
Eb, Dizhe, et al.. (2002). [Delivery of "suicide" thymidine kinase gene of herpes virus in the complex with cationic peptide into human hepatoma cells in vitro].. PubMed. 44(5). 455–62. 5 indexed citations
19.
Sa, Dambinova, et al.. (1997). The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy. Journal of the Neurological Sciences. 152(1). 93–97. 16 indexed citations
20.
Гуревич, В. С., David Lominadze, Ayotunde S.O. Adeagbo, et al.. (1997). Antithrombotic and Vasorelaxant Properties of a Novel Synthetic RGD Peptide Containing Nitric Oxide. Pharmacology. 55(1). 1–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Karnaukhova Breakdown of academic impact, for papers by Craig T. Armstrong Breakdown of academic impact, for papers by Meifang Yu Breakdown of academic impact, for papers by Biswarup Saha Breakdown of academic impact, for papers by Silvia Ronchi Breakdown of academic impact, for papers by N. Sukumar Breakdown of academic impact, for papers by Amy B. Foraker Breakdown of academic impact, for papers by Amy Schutz‐Geschwender Breakdown of academic impact, for papers by Wendi V. Rodrigueza
Rankless by CCL
2026